Orally Active Multi-Functional Antioxidants Delay Cataract Formation in Streptozotocin (Type 1) Diabetic and Gamma-Irradiated Rats by Randazzo, James et al.
Orally Active Multi-Functional Antioxidants Delay
Cataract Formation in Streptozotocin (Type 1) Diabetic
and Gamma-Irradiated Rats
James Randazzo
1, Peng Zhang
1, Jun Makita
1, Karen Blessing
1, Peter F. Kador
1,2*
¤
1Department of Pharmaceutical Sciences, University of Nebraska Medical Center, Omaha, Nebraska, United States of America, 2Department of Ophthalmology, University
of Nebraska Medical Center, Omaha, Nebraska, United States of America
Abstract
Background: Age-related cataract is a worldwide health care problem whose progression has been linked to oxidative stress
and the accumulation of redox-active metals. Since there is no specific animal model for human age-related cataract,
multiple animal models must be used to evaluate potential therapies that may delay and/or prevent cataract formation.
Methods/Principal Findings: Proof of concept studies were conducted to evaluate 4-(5-hydroxypyrimidin-2-yl)-N,N-
dimethyl-3,5-dioxopiperazine-1-sulfonamide (compound 4) and 4-(5-hydroxy-4,6-dimethoxypyrimidin-2-yl)-N,N-dimethyl-
3,5-dioxopiperazine-1-sulfonamide (compound 8), multi-functional antioxidants that can independently chelate redox
metals and quench free radicals, on their ability to delay the progression of diabetic ‘‘sugar’’ cataracts and gamma radiation-
induced cataracts. Prior to 15 Gy of whole head irradiation, select groups of Long Evans rats received either diet containing
compound 4 or 8, or a single i.p. injection of panthethine, a radioprotective agent. Compared to untreated, irradiated rats,
treatment with pantethine, 4 and 8 delayed initial lens changes by 4, 47, and 38 days, respectively, and the average
formation of posterior subcapsular opacities by 23, 53 and 58 days, respectively. In the second study, select groups of
diabetic Sprague Dawley rats were administered chow containing compounds 4, 8 or the aldose reductase inhibitor AL1576.
As anticipated, treatment with AL1576 prevented cataract by inhibiting sorbitol formation in the lens. However, compared
to untreated rats, compounds 4 and 8 delayed vacuole formation by 20 days and 12 days, respectively, and cortical cataract
formation by 8 and 3 days, respectively, without reducing lenticular sorbitol. Using in vitro lens culture in 30 mM xylose to
model diabetic ‘‘sugar’’ cataract formation, western blots confirmed that multi-functional antioxidants reduced endoplasmic
reticulum stress.
Conclusions/Significance: Multi-functional antioxidants delayed cataract formation in two diverse rat models. These studies
provide a proof of concept that a general cataract treatment focused on reducing oxidative stress instead of a specific
mechanism of cataractogenesis can be developed.
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Introduction
Cataract is a major worldwide health care problem that
especially affects the elderly. It is the leading cause of preventable
blindness in the world, especially in developing countries in Africa
and Asia [1,2]. Currently, the only treatment for cataracts is the
surgical removal of the opaque lens. With the worldwide aging
population expected to increase four-fold [3], age-related cataracts
are expected to become a major public health problem in terms of
both increasing the number of required surgeries and the financial
burden associated with these surgeries. Therefore, the develop-
ment of a nonsurgical treatment for cataracts would have a
profound beneficial impact not only on human health but also
healthcare costs [1,4,5]. In fact, it has been estimated that a 10
year delay in cataract formation could reduced the need for
cataract surgery by 50% [6]. Therefore the development of an
efficacious anti-cataract drug would have a beneficial impact on
both human health and healthcare costs.
Cataracts is a multi-factorial disease with important risk and/or
modifying factors such as race, heredity, smoking, UV exposure,
nutritional inadequacies, diabetes, and aging all contributing to
cataract formation [5,7,8]. A common factor in most cataracts is
oxidative stress [7,8]. As within the lens, there is an age-dependent
decrease in antioxidant defenses and an increase in the
accumulation of redox-active metals such as iron and copper
[9]. This results in hydrogen peroxide being able to interact with
free iron to form cytotoxic hydroxyl radicals via the Fenton
reaction.
A major impediment in the development of anti-cataract drugs
is the lack of a specific animal model that mirrors the biochemical,
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Therefore, the development of potential anti-cataract drugs
requires their evaluation in multiple diverse animal models. For
example, radiation of various intensities can induce cataracts in
rats as a result of lens crystallin oxidation by free radicals/reactive
oxygen species (ROS) [10]. Exposure to at least 2 Gy of gamma
radiation has been documented to result in cataract formation
after a dose-dependent latency period [11,12,13]. The deleterious
effect of gamma rays on the lens is mediated by the radiolysis of
water to hydrogen peroxide (H2O2) and hydroxyl radicals (OH
N)i n
an aqueous environment and the formation of superoxide (O2
2N)
in an aerobic environment [14]. Of the ROS generated, hydroxyl
radicals are the most reactive and they are considered to be the
primary initiators of oxidative damage. Superoxide and hydrogen
peroxide typically lack sufficient reactivity to oxidize critical
biological macromolecules [15]. However, in the presence of
redox reactive metals such as iron hydrogen peroxide and
superoxide may undergo the Fenton and Haber-Weiss reactions
that produce the stronger hydroxyl radicals [16]. Gamma
radiation-generated superoxide has also been shown to cause the
release of iron from ferritin, which can enhance the production of
hydroxyl radicals that lead to DNA, protein, and lipid damage
[14].
Another commonly used cataract model is the diabetic rat
which has been established to develop sugar cataracts due to the
aldose reductase (AR) catalyzed reduction of glucose to sorbitol
[17,18]. The intracellular accumulation of sorbitol results in
hyperosmotic effects that can induce cellular swelling that initiates
a cascade of biochemical steps that results in lens opacification.
Among these steps is the osmotic induction of endoplasmic
reticular (ER) stress [19,20] which then can initiate an unfolded
protein response (UPR) that generates ROS and apoptotic
signaling. This generation of ROS has been reported by a number
of investigators [21,22,23,24].
Recently, we have synthesized a novel series of compounds that
include 4-(5-hydroxypyrimidin-2-yl)-N,N-dimethyl-3,5-dioxopiper-
azine-1-sulfonamide and 4-(5-hydroxy-4,6-dimethoxypyrimidin-
2-yl)-N,N-dimethyl-3,5-dioxopiperazine-1-sulfonamide (Figure 1),
that contain both a unique 2-amino-5-hydroxy-1,3-pyrimidine
radical scavenging system and a 2,6-dioxipiperazine moiety that is
able to chelate redox reactive metal ions such as iron and copper
[25]. These compounds, referred to as compounds 4 and 8,
respectively, in the previous publication, are called multi-functional
antioxidants because their radical scavenging and chelation ability
are independent of each other. In cultured human lens epithelial
cells (hLECs), these compounds reduced ROS generated both
by either hydrogen peroxide or the Fenton reaction (iron and
hydrogen peroxide) [25]. Here we demonstrate that oral adminis-
tration of these compounds reduces the ROS-initiated progression
of cataracts associated with gamma irradiation or osmotic stress in
rats.
Materials and Methods
Materials
All reagents used were of reagent grade. Multi-functional
antioxidants 4-(5-hydroxypyrimidin-2-yl)-N,N-dimethyl-3,5-diox-
opiperazine-1-sulfonamide (4) and 4-(5-hydroxy-4,6-dimethoxy-
pyrimidin-2-yl)-N,N-dimethyl-3,5-dioxopiperazine-1-sulfonamide
(8) (99+% pure by HPLC) were synthesized as previously
described [25]. The aldose reductase inhibitor, spiro-(2,7-
difluoro-7H-fluorene-9,49-imidazolidine)-29-59-dione (AL1576),
was obtained from Alcon Laboratories (Fort Worth, TX). Anti-
glucose-regulated protein 78/binding immunoglobulin protein
(GRP78/Bip) was obtained from Abcam, Inc. (Cambridge, MA)
and used at a dilution of 1:2000. Chemiluminescent reagents and
pre-stained and biotinylated protein ladders were obtained from
Cell Signaling Technology (Danvers, MA). 4–15% Tris-HCl
Ready Gel Precast gels and Trans-BlotH nitrocellulose membrane
were obtained from Bio-Rad Laboratories (Hercules, CA). Nova
Max Blood Glucose Monitoring system was obtained from Nova
Biomedical (Waltham, MA). Bayer A1cNow test kits for
glycosylated hemoglobin (HbA1c) were purchased from Bayer
Health Care LLC. (Tarrytown, NY).
Animal Care
All procedures were performed in strict accordance with the
recommendations in the Guide for the Care and Use of
Laboratory Animals of the National Institutes of Health and
approved by the Institutional Animal Care and Use Committee of
UNMC (Permit Number: 05-102-01).
In vivo Irradiated Studies in Rats
Whole head gamma irradiation was conducted on 24 male
pigmented Long Evans (150–200 g) rats. Prior to irradiation, these
rats were randomly divided into 4 equal groups with Group 1
receiving standard rodent diet (untreated), Group 2 receiving
standard rodent diet and the radioprotective agent pantethine,
Group 3 receiving standard rodent diet supplemented with 0.025
wt% of compound 4, and Group 4 receiving standard rodent chow
supplemented with 0.025 wt% of compound 8. Chow based
treatments were initiated 14 days prior to whole head gamma
irradiation and were continued until the study was terminated.
Pantethine (1 g/kg i.p.) was administered 45 minutes prior to
irradiation as described by Clark [26]. Each rat was placed in a
standard plastic rat restraint and received 15 Gy of whole head
gamma radiation (6000 Curie Cobalt-60 Source, UNMC
Experimental Radiation Facility) at a rate of 0.341 Gy/min while
unanesthetized. Following irradiation, each group of rats were
housed three to a cage and provided water ad libitum. Because
radiation reduces salivary gland function and causes dental
Figure 1. Structure of multi-functional compounds 4 (left) and
8 (right).
doi:10.1371/journal.pone.0018980.g001
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Diet
TM supplemented with/without compounds 4 or 8 (Bio-Serv,
Frenchtown, NJ) for the first 45 days post-irradiation. The groups
were then returned to standard rodent diet with/without
supplementation with compounds 4 or 8. Body weight and food
intake was monitored at 3–4 day intervals. Lens changes,
monitored weekly by portable slit lamp following dilation with
1% Tropicamide, were evaluated as described by Livesy et al as
follows –0: Clear; 1: Posterior subcapsular (PSC) haze; 2: Spokes,
suture enhancement and powdery PSC deposits; 3: Prominent
PSC punctate opacities with spokes and suture enhancement; 4:
PSC opacity blocks appearance of retinal vessels; 5: Start of
cortical involvement; and 6:Total lens opacity, visible with naked
eye [27]. At the end of the study, all rats were euthanized by
carbon dioxide asphyxiation, and their eyes were enucleated. The
lenses were then carefully removed from the enucleated eyes by a
posterior approach and frozen on dry ice for subsequent analysis.
In vivo Diabetic Studies in Rats
Diabetes was induced in young (100 g) Sprague Dawley rats by
tail vein injection of streptozotocin (75 mg/kg i.v.) as previously
described [28]. Rats with blood glucose levels greater than
300 mg/dL were considered diabetic and divided equally into
four groups of eight each. The first diabetic group received
standard rat diet (untreated), the second and third diabetic group
received standard rodent chow supplemented with either 0.05
wt% of compound 4 or 8, and the fourth diabetic group received
standard rodent chow containing 0.0125 wt% of the aldose
reductase inhibitor (ARI) AL1576. Age-matched, non-diabetic rats
receiving standard rodent chow were used as controls. Diets
supplemented with compounds 4, 8 or AL1576 were initiated five
days following the initial streptozotocin injection and were
continued until the end of the study. Rats were housed two to a
cage and water was provided ad libitum. Body weight and food
intake were monitored every 2–4 days. Lens changes in the rats
were monitored by portable handheld slit lamp (Kowa Co Ltd.,
Tokyo, Japan) following mydriasis with 1% tropicamide at 3–4
days intervals. Lens opacification was evaluated on a scale of 0 to 3
[29]. Cataract progression of was scored as follows: 0, clear; 1.0,
appearance of some equatorial vacuoles; 1.2, peripheral equatorial
vacuoles; 1.4, obvious vacuole formation in ,50% of lens; 1.6,
obvious vacuole formation in .50% of lens; 1.8, total lens covered
with vacuoles; 2.0, start of cortical opacity formation; 2.2,
posterior capsule still visible by slit lamp; 2.4, easily detectable
cortical opacity; 2.6, cortical opacity expanded to entire lens; 2.8,
lens appears totally white; and 3, mature. Blood glucose levels at
the start and end of the study were evaluated with a Nova Max
blood glucose meter (Nova Biomedical, Waltham, MA). At the end
of the study, rats were euthanized by carbon dioxide asphyxiation,
blood was collected via cardiac puncture, and the eyes were
enucleated. The lenses were carefully removed by a posterior
approach from the enucleated eyes and frozen on dry ice for
subsequent analysis.
Lenticular Levels of Compounds 4 and 8
Lenses from diabetic and irradiated rats were homogenized in
ground glass homogenizers with 2 mL of PBS containing 0.4 mM
N,N-Dimethyl-4-(pyrimidin-2-yl)piperazine-1-sulfonamide as the
internal standard. The homogenates were centrifuged for 5 min at
15,000 g at 4uC. Protein concentration in an aliquot of each
supernatant was determined as previously described [30]. The
remaining supernatant was then deproteinized with equal volumes
of 0.3 N zinc sulfate and 0.3 N barium hydroxide [31]. Following
an additional centrifugation at 15,000 g for 30 minutes at 4uC, the
supernatant was transferred to a clean test tube and dried in vacuo.
The remaining solid residue was suspended in HPLC grade
chloroform and filtered through a 0.45 micron filter to remove
particulates. The filtrate was again dried in vacuo and the
remaining organic soluble residue containing both the internal
standard and either extracted compound 4 or 8 was dissolved in
HPLC grade acetonitrile. Samples (20 mL) were analyzed by an
automated Hewlet Packard 1100 HPLC (Agilent Technologies,
Santa Clara, CA) equipped with a Luna 5 mm C18, 25064
column (Phenomenex Inc., Torrance, CA) at 25uC by elution with
50% aqueous methanol. The eluted compounds were monitored
spectrophotometrically at 247 nm with a diode array detector and
by ESI-MS (Thermo Finnigan LCQ; Thermo Fisher Scientific,
Waltham, MA). Samples were quantified against constructed UV
and ESI-MS standard curves of compounds 4 and 8. All analyses
were conducted in triplicate.
Determination Lenticular Sorbitol Levels
Individual lenses from each of the in vivo groups were
homogenized in a ground glass homogenizer containing 2 mL of
PBS and three micromoles of the internal standard, xylitol. An
aliquot of each lens homogenate was removed for protein
quantification [30]. The remaining homogenate was then
deproteinized by overnight centrifugation in YM-10 Microcon
centrifugal filters (Millipore, Billerica, MA) at 8uC. Each filtrate
was then dried in vacuo, dissolved in pyridine, and derivatized with
phenyl isocyanate at 55uC for 60 min. After cooling, the reaction
was halted by the addition of ice cold methanol. The derivatized
samples (5 mL) were analyzed by reverse-phase HPLC on an
automated Hewlet Packard 1100 (Agilent Technologies, Santa
Clara, CA) equipped with a 15064.6 mm TSK-GEL ODS-80Tm
column (Tosoh Bioscience LLC, King of Prussia, PA) at 35uC.
Samples were isocratically eluted with 20 mM potassium phos-
phate/acetonitrile (35:65 v%) buffer, pH 7.0, at a flow rate of
1.0 ml/min. Samples were detected at 235 nm and quantified
against standard curve of sorbitol (0.008–6.0 mmol).
In Vitro ‘Diabetic’ Lenses Culture Studies
Young (100 g) Sprague Dawley rats were euthanized by carbon
dioxide asphyxiation and their eyes were enucleated. Each lens
was carefully removed by a posterior approach and placed in
2 mL of sterile TC-199 - bicarbonate media containing 30 mM
fructose and 2% penicillin-streptomycin (culture media). To
ensure that the lens was not damaged during dissection, each
lens was first incubated for 4 hrs in a humidified incubator under
95% air and 5% CO2 at 37uC and checked for clarity [32]. All
clear lenses were then equally divided into five groups and
incubated for an additional 24 hrs as follows: Group 1: Culture
media containing 30 mM fructose; Group 2: Culture media
containing 30 mM xylose; Group 3: Culture media containing
30 mM xylose +0.1 mM AL1576; Group 4: Culture media
containing 30 mM xylose +0.1 mM compound 4; and Group 5:
Culture media containing 30 mM xylose +0.1 mM compound 8.
After 24 hours, each lens was examined for morphological
changes and the lens capsule containing the epithelial cells and
superficial cortical fibers was removed and immediately frozen for
subsequent analysis.
Endoplasmic Reticulum Stress Determination
The thawed capsules from the cultured lenses were homoge-
nized in ground glass homogenizers containing a mixture of RIPA
buffer (Cell Signaling Technology, Danvers, MA) and Halt
Protease and Phosphatase Inhibitor Cocktails (VWR Interna-
tional, West Chester, PA). Total protein concentrations were
Multi-Functional Antioxidants Delay Cataract
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were prepared in SDS-PAGE sample buffer and loaded onto
precast polyacrylamide gels. Following electrophoresis, the sepa-
rated proteins were transferred onto nitrocellulose membranes,
blocked with 5% nonfat dry milk in TBS containing 0.1% Tween-
20 (TBST), and incubated overnight at 4uC with primary
antibodies for ER Stress (GRP78/Bip) and internal loading
control (GAPDH). The membranes were washed three times with
TBST and incubated with a secondary antibody conjugated with
horseradish peroxidase (HRP) for 1 hour. The specific protein
bands were visualized by incubating the membrane with luminol
reagent and exposing the membrane to X-ray film. After digitizing
the x-ray film image, the protein levels were quantified using the
NIH ImageJ program (http://rsbweb.nih.gov/ij/). Comparative
expression of GRP78/Bip was assessed by normalizing the total
GRP78/Bip pixel volume (pixel density X area) to that of the
respective GAPDH band.
Statistical Analyses
Calculations were conducted using Microsoft Excel 2007
(Microsoft, Redmond, WA). Statistical analyses (ANOVA) were
conducted using OriginProH software version 8.1 (OriginLab
Corp., Northampton, MA). Significant differences were defined as
having a p,0.05.
Results
Efficacy of Compounds 4 and 8 on Cataract Formation in
Gamma-irradiated Pigmented Rats
To determine if the multi-functional antioxidants can protect
against radiation-induced cataracts, pigmented Long Evans rats
received 15 Gy of gamma radiation (Cobalt 60 source) to the
whole head, an amount established to result in 100% incidence of
cataract development in albino animals [27,33]. Twenty four 150–
200 g Long Evans rats were split into four equal groups and all
rats in each group received whole head radiation. Group 1
received standard rodent diet (untreated control). Group 2 also
received standard rodent diet, but received pantethine, a known
radioprotectant, by intraperitoneal injection 45 minutes prior to
irradiation (1 g/kg) as previously described [26]. Groups 3 and 4
were administered standard rodent diet supplemented with either
0.025 wt% of compound 4 or 8 for two weeks prior to whole head
irradiation and continued for the duration of the study.
It is established that whole head radiation results in a temporary
loss of salivary gland function and dental problems. Therefore, all
rats immediately received Nutra-Gel Diet
TM supplemented with/
without compounds 4 or 8 (Bio-Serv, Frenchtown, NJ) after 15 Gy
of whole head gamma radiation (UNMC Experimental Radiation
Facility). This diet is a nutrient and mineral equivalent ‘‘soft’’ diet
designed for these types of experiments. Body weights were
monitored to determine the effect of radiation on the rat’s ability
to feed. One week following radiation, untreated and panthethine-
treated rats lost 10% of their body weights while similar rats
treated with either compound 4 or 8 only lost 4%, suggesting that
there was an improvement in the overall health in the multi-
functional treated rats (Figure 2). After 14 days the body weights in
the pantethine-treated group increased to the levels of the 4- and
8-treated irradiated rats had similar, enhanced body weights
compared to untreated, irradiated control and by 21 days, all
groups displayed similar weights. No difference in body weights
was observed after 21 days post-irradiation (Figure 2). After
salivary gland function returned and incisors regrew, all groups
were returned to the solid standard rodent diet supplemented
with/without compounds 4 or 8. Feed records indicated that rats
in groups 3 and 4 ingested an average dosage 6 S.D. (mg/kg/day)
of 25.061.5 for compound 4 and 26.661.6 for compound 8 prior
to irradiation. Post irradiation, rats ingested an average of
17.565.5 mg/kg/day (mean 6 S.D.) of compound 4 and
18.265.8 mg/kg/day (mean 6 S.D.) of compound 8 as the
weight percent supplementation remained constant.
The progression of radiation-induced cataracts has been
described and subjectively monitored using a scale of 0 and 6
[27]. In the present studies, lens changes were moitored weekly by
slit lamp following tropicamide mydriasis. As illustrated in Figure 3,
initial lens changes appeared ca. 65 days after irradiation as a
Figure 2. Comparison of weights of untreated, 4-treated, 8-
treated, and pantethine-treated Long Evans rats post-irradia-
tion. Treated rats weighed significantly more than untreated, irradiated
rats. Mean 6 S.D.; n=6 rats. An asterisk (*) denotes a significant
difference (p,0.05) when compared to untreated, irradiated rats.
doi:10.1371/journal.pone.0018980.g002
Figure 3. Progression of radiation-induced cataract formation.
Figure illustrates a comparison of cataract score observed in whole
head, gamma-irradiated rats treated with/without the radioprotectant,
pantethine, or multi-functional antioxidants 4 and 8. Values represent
mean 6 SEM; n=6. An asterisk (*) denotes a significant difference
(p,0.05) when compared to untreated, irradiated rats.
doi:10.1371/journal.pone.0018980.g003
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followed by the appearance of spokes, suture accentuation, and a
progressive increase in PSC opacification (ca. 75 days) that resulted
in the appearance of punctate opacities (ca. 90 days) that gradually
increased in density so that visualization of the retina became
difficult (ca. 150 days). Eventually by 180 days the entire lens
became opaque, but mature cataracts were not found. Treatment
with pantethine and multi-functional antioxidants 4 and 8 delayed
the appearance of these lens opacities; however, the effect of
pantethine was minimal. Cataract delay was assessed by
calculating the time required for 50% of each group to develop
PSC clouding or prominent PSC punctate opacities (Figures 4, 5).
Compared to untreated irradiated rats, treatment with pantethine,
4 and 8 delayed the initial formation of PSC haze by 4, 47 and 38
days, respectively, and delayed the average formation of
prominent PSC punctate opacities by 23, 53 and 58 days,
respectively.
At the end of the study, the lenses were analyzed for the
amounts of compounds 4 and 8 present in the avascular lens.
Analysis by HPLC-MS indicated that 417641 ng/mg protein of
compound 4 and 267636 ng/mg protein of compound 8 were
present in the irradiated lenses (Figure 6A).
Efficacy of Compounds 4 and 8 on Delaying Diabetic
‘Sugar’ Cataracts
While it is established that diabetic cataracts are initiated by the
aldose reductase (AR) catalyzed accumulation of sorbitol,
antioxidants have been reported to delay diabetic cataract
formation. Therefore, multi-functional compounds 4 and 8 were
evaluated for their ability to delay cataract formation. Following
induction of diabetes in young rats by tail vein injection of strep-
tozotocin (STZ), all rats with blood glucose levels .300 mg/dL
were divided into four equal groups of eight rats. Group 1 received
normal chow (untreated diabetic control), group 2 received chow
containing 0.0125% of the aldose reductase inhibitor (ARI)
AL1576, group 3 received chow containing 0.05% of compound
4, and group 4 received chow containing 0.05% of compound 8.
A fifth group was composed of non-diabetic, age-matched control
rats. Feeding records indicated that the diabetic rats ingested an
average dosage 6 S.D. of 48.763.5 mg/kg/day of compound 4,
48.962.6 mg/kg/day of compound 8, and 22.862.1 mg/kg/day
of AL1576. As summarized in Table 1, hyperglycemia among the
diabetic groups did not significantly differ as measured by both
blood sugar and glycosylated hemoglobin levels indicating that
neither the multi-functional antioxidants nor ARI affected
hyperglycemia. Furthermore, treatment with antioxidants did
not significantly affect the body weights of the diabetic animals
(Figure 7); however, the rats treated with compound 4 appeared
on average to eat slightly more during the course of the study and
therefore weighed slightly more.
Lens opacities, as monitored by portable slit lamp at 3–4 day
intervals, rapidly developed in the untreated, diabetic rats, with
vacuole formation detected by 12 days. Treatment with compound
4 and 8 delayed the initial appearance of vacuoles by 26 and 3
days, respectively (Figure 8). Cortical opacities formed by 29 days
in all untreated diabetic rats and these were delayed in all 4-
treated and 8-treated, diabetic rats. At the end of the 7 week study
all untreated diabetic rats had developed dense cortical cataracts
while those treated with either antioxidant displayed cortical
opacities where the posterior capsule was still visible.
Cataract progression, assessed as the time required for 50% of
diabetic rats in each group to develop equatorial vacuoles or
cortical opacities, are summarized in Figure 9 and 10. Vacuole
formation was delayed by 20 days in 4-treated rats and 12 days in
8-treated rats and (Figure 9). A similar trend was observed for
cortical cataract formation where treatment with compounds 4
and 8 delayed cortical cataracts by 8 and 3 days, respectively
(Figure 10). No lens changes were observed in either the non-
diabetic control rats or the diabetic rats treated with the aldose
reductase inhibitor AL1576 (Figures 9, 10).
At the end of the study, lenses were removed and analyzed for
sorbitol levels according as previously described [34]. Analyses
showed that sorbitol accumulation was similar in the untreated
diabetic and both multi-functional treated diabetic rats (Figure 11).
Sorbitol was absent in the lenses from non-diabetic control rats
and diabetic rats treated with the ARI, AL1576. Therefore, the
Figure 4. Percentage of animals progressing to PSC clouding
(cataract score of 1.5) in gamma-irradiated rats treated with/
without radioprotectant, pantethine, or multi-functional anti-
oxidants 4 and 8. Values represent percentage of the 6 animals in
each group. Delay was calculated based on the number of days
required for 50% of the population to achieve this level of lens opacity
(dotted line).
doi:10.1371/journal.pone.0018980.g004
Figure 5. Percentage of animals progressing to prominent PSC
punctate opacities (cataract score 3) in gamma-irradiated rats
treated with/without radioprotectant, pantethine, and multi-
functional antioxidants 4 and 8. Values represent percentage of the
6 animals in each group. Delay was calculated based on the number of
days required for 50% of the population to achieve this level of lens
opacity (dotted line).
doi:10.1371/journal.pone.0018980.g005
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AR inhibition. Lens levels of compounds 4 and 8 measured by
HPLC-MS were 412633 ng/mg protein and 206617 ng/mg
protein, respectively (Figure 6B).
Effect of Compounds 4 and 8 on Endoplasmic Reticulum
Stress In Vitro
Sorbitol-linked osmotic stress in lens epithelium cells has
recently been reported to induce ER stress that leads to the
generation of ROS.
To determine whether the observed delay of the multi-
functional antioxidants in diabetic cataracts is linked to ER stress,
the levels of glucose-regulated protein 78/binding immunoglob-
ulin protein (GRP78/Bip), a marker for ER stress, were evaluated
in rat lenses cultured in vitro. Since opacities do not rapidly form in
vitro when rat lenses are with glucose, xylose was substituted for
glucose because xylose is more rapidly reduced to xylitiol by AR.
After 24 hr of culture lens cortical opacities formed in all lenses
cultured in 30 mM xylose with/with compounds 4 or 8; however,
opacities were absent in lenses cultured in xylose media containing
AL1576. Similarly, control lenses cultured for 24 hr in TC-199
fructose media remained clear. Compared to the control cultured
lenses, expression of GRP78/Bip in xylose cultured lenses was
significantly induced (Figure 12). This expression was reduced in
lenses treated with either compounds 4, 8, or AL1576. Since
compounds 4 and 8 do not reduce sorbitol by inhibiting AR, their
delay of cataract formation must be downstream of the osmotic
effect that induces GRP78/Bip and generates ROS.
Discussion
Age-related cataracts are considered to be multi-factorial in
origin, with ROS mediated oxidative damage considered to be a
common factor [7,35,36]. Iron concentrations also increase in the
ageing lens and a major route to damaging ROS formation is
through the Fenton reaction, which produces hydroxyl radicals
using iron as the catalyst [37]. In the present study two multi-
functional antioxidants 4 and 8, which independently scavenge
free radicals and chelate iron [25,38,39,40,41,42] have been
evaluated for their ability to delay cataract formation in two
animal models where oxidative stress has been reported
[10,11,12,13,19,20].
Figure 6. Lenticular levels of investigational compounds 4 and 8. A Accumulation in the irradiated lens after 28 weeks of feeding. B Similar
accumulation of compounds 4 and 8 in the diabetic lens following feeding of diet supplemented with 0.05% compounds 4 and 8 for 7 weeks. Mean
6 S.E.M.; n=6. A pound sign (#) denotes a significant difference (p,0.05) when compared to the 4-treated group.
doi:10.1371/journal.pone.0018980.g006
Figure 7. Average weights of non-diabetic control and
untreated, 4-treated, 8-treated, and AL1576-treated diabetic
Sprague Dawley rats. Mean 6 S.D.; n=8 rats.
doi:10.1371/journal.pone.0018980.g007
Table 1. Level of hyperglycemia in rats.
Blood Glucose * HbA1c
#
Day 0 Day 49 Day 49
Non-diabetic Control 197.8618.8 223.9615.0 4.860.08
Untreated Diabetic 455.4623.2 600.060.0 12.960.07
Diabetic + AL1576 508.3630.2 591.268.2 12.860.18
Diabetic + 4 497.3631.2 600.060.0 12.860.11
Diabetic + 8 518.0627.8 600.060.0 12.860.14
*Blood sugar levels were determined at the initial start of the study (Day 0) and
the end of the study (Day 49). Values read as HIGH (above 600 mg/dL) on the
glucometer were averaged as 600. Mean 6 SEM; n=8.
#Glycosylated hemoglobin (HbA1c) levels were also determined at the end (day
49) of the study. Levels .13% were averaged in as 13%. While ‘‘stress’’ can
increase blood sugar levels, the HbA1c levels indicate that all diabetic rats
were equally hyperglycemic over the study period. Mean 6 SEM; n=8.
doi:10.1371/journal.pone.0018980.t001
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form cataracts after a dose-dependent latency period [11,12,13].
The deleterious effect of gamma rays on the lens is mediated by
the radiolysis of water to hydrogen peroxide (H2O2), hydroxyl
radicals (OH
N), and superoxide (O2
2N) [14]. Of these reactive
oxygen species, the hydroxyl radicals are considered to be the
primary initiators of oxidative damage, while superoxide and
hydrogen peroxide typically lack the sufficient reactivity to oxidize
critical biological macromolecules [15]. Gamma radiation-gener-
ated superoxide has also been shown to cause release of iron from
ferritin, which can enhance production of hydroxyl radicals
through the Fenton and Haber-Weiss reactions leading to DNA,
protein, and lipid damage [14].
As expected, 15 Gy of whole head irradiation resulted in
damage to the salivary glands. It was noted that rats pre-treated
with either compound 4 or 8 lost 4% of their body weights
compared to a 10% loss in untreated rats, suggesting that these
compounds were radioprotective. Since pantethine has been used
as a radioprotectant, these compounds could potentially be co-
administered with pantethine to synergistically protect against
radiation. However, further studies are required to confirm this
observation. Radiation damage to the lens is typically first
observed as PSC opacities [43,44]. In pigmented animals, PSC
opacities were observed after a latency period of eight weeks,
compared to the 5 weeks typically seen in albino animals [27].
This extended latency period may be due in part to the pigment of
the iris, but may also reflect strain differences in the lens, as
suggested by observations that lenses from pigmented animals are
more tolerant to UV radiation in vitro [45]. Initial lens changes
appeared as a diffuse PSC clouding (haze) which progressed to
dense PSC opacification and punctate opacities that blocked
visualization of the retina. At the end of the study, total lens
opacification, but not mature cataracts, were present. A number of
studies have reported the use of antioxidants and phase transition
inhibitors to delay radiation-induced cataracts in albino rats
[10,26,27,46,47,48,49,50]. In the present studies using pigmented
rats, treatment with pantethine and multi-functional antioxidants
4 and 8 delayed the appearance of lens opacities. However, the
delay by pantethine was minimal, unlike the marked delay
observed in irradiated albino animals [26]. The observed delay by
the multi-functional antioxidants correlated with the lenticular
presence of multi-functional 4 and 8 in the lens.
Another common model for cataract formation is the diabetic
rat. Chronic hyperglycemia results in severe metabolic imbalances
and non-physiological changes in many tissues, including the
formation of a diabetic ‘sugar’ cataract [51,52]. This process is
initiated when glucose is reduced to its sugar alcohol, sorbitol, by
the enzyme AR [18]. Hyperosmotic effects result from the
accumulation of sorbitol in the lens epithelium and initiate ER
stress [19,20]. As sorbitol accumulates primarily in the epithelium
and superficial lens fibers of the diabetic lens, free radical
production is increased and natural antioxidant defenses are
compromised. This results in increased oxidative stress [21,22,23]
and apoptotic signaling. Inhibiting sorbitol induced osmotic stress
in the rat lens by the administration of ARIs prevents the
Figure 8. Progression of sugar cataract formation in strepto-
zotocin-induced diabetic rats treated with/without the ARI,
AL1576, and multi-functional antioxidants 4 and 8. Values
represent mean 6 SEM; n=8. An asterisk (*) denotes a significant
difference (p,0.05) when compared to untreated, diabetic rats.
doi:10.1371/journal.pone.0018980.g008
Figure 9. Percentage of animals progressing to equatorial
vacuoles (cataract score 1) in diabetic rats treated with/without
the ARI, AL1576, or multi-functional antioxidants 4 and 8.
Values represent percentage of the 8 animals in each group. Delay was
calculated based on the number of days required for 50% of the
population to achieve this level of lens opacity (dotted line).
doi:10.1371/journal.pone.0018980.g009
Figure 10. Percentage of animals progressing to cortical
opacities (cataract score 2) in diabetic rats treated with/
without the ARI, AL1576, or multi-functional antioxidants 4
and 8. Values represent percentage of the 8 animals in each group.
Delay was calculated based on the number of days required for 50% of
the population to achieve this level of lens opacity (dotted line).
doi:10.1371/journal.pone.0018980.g010
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[18]. Reducing oxidative stress can only delay cataract formation
as demonstrated by the antioxidants butylated hydroxytoluene
(BHT) [53,54], Trolox (6-hydroxy-2,5,7,8-tetramethyl-chroman-
2-carboxylic acid) [55], and vitamin E [56].
Antioxidants cannot prevent sorbitol accumulation; however,
the overall shift of the treated graphs to the right in Figure 8
indicates a delay in cataract progression presumably by reducing
the effects of generated ROS. The absence of cataract formation
in AL1576-treated animals is consistent with previously published
reports on the effects of ARI treatment on ocular pathology in
diabetic animals [57]. Compounds 4 and 8 were able to delay
cataract formation without affecting blood sugars (Table 1) or
lenticular sorbitol levels (Figure 11). The presence of compounds 4
and 8 in the lens strongly suggests that the delays in cataract
formation observed in both animal models are linked to their
lenticular levels.
These proof of concept studies represent the first step in the
potential development of these compounds as therapeutics agents.
Clearly, the development of these compounds requires important
pharmacokinetic and pharmacodynamic (PK/PD) studies to
determine important parameters such as the minimal therapeutic
Figure 11. Lens sorbitol accumulation in streptozotocin diabetic rats treated with/without the ARI, AL1576, or multi-functional
antioxidants 4 and 8. Values represent mean 6 SEM; n=8. An asterisk (*) denotes a significant difference (p,0.05) when compared to untreated,
diabetic rats.
doi:10.1371/journal.pone.0018980.g011
Figure 12. Expression of GRP78/Bip in cultured lenses. Top: Comparison of expression of GRP78/Bip normalized to GAPDH levels in rats lenses
cultured in TC-199 bicarbonate media with/without compounds 4, 8 or AL1576. Lenticular protein homogenate was subjected to Western blotting
with anti-GRP78/Bip and anti-GAPDH antibodies. Bottom: Lane 1, media containing 30 mM fructose (control); Lane 2, media containing 30 mM
xylose; Lane 3, media containing 30 mM xylose +0.1 mM AL1576; Lane 4, media containing 30 mM xylose media +0.1 mM compound 4, Lane 5,
media containing 30 mM xylose +0.1 mM compound 8. Samples were loaded onto the gel in different order than the graph. Therefore, fructose and
xylose lanes had to be cut and flipped horizontally using Adobe Photoshop. Pixel intensity was analyzed by ImageJ software. Mean 6 S.D.; n=6. An
asterisk (*) denotes a significant difference (p,0.05) when compared to lenses cultured in fructose control media. A pound sign (#) denotes a
significant difference (p,0.05) when compared to untreated lenses cultured in 30 mM xylose media.
doi:10.1371/journal.pone.0018980.g012
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maximum tolerated dose, the lethal dose, and the half life of the
drug (t1/2). Efficacy studies where the time to catraract formation
(pharmacological endpoint) of these compounds at their ED50 is
determined, requires repeating the present study at a minimum of
three additional doses so that a dose-response curve can be
constructed for estimating the ED50. These dose-response curves
would also allow us to estimate the minimal therapeutic dose
(MTD). However, such efficacy studies are also directly linked to
the turnover of drug in the lens. In the present experiments,
similar lens levels of compounds were achieved (Figure 6) despite
different doses being administered, This suggests that the lenticular
half-life of compounds 4 and 8 is a key factor in determining the
MTD.
In the current studies, the approximate 80 mg/kg/day dose
used was based on experience where such a dose by a majority of
ARIs either prevented or significantly delayed diabetic cataract
formation as illustrated by the laboratories of Kador [28,29,58]
and Kinoshita [59,60,61]. Since the synthesis of compounds 4 and
8, as described by Jin et al. [25], is straight-forward, we believe
that the synthetic scheme is amenable to scaled-up GMP
production. In the present studies, the study durations versus the
amount of synthesized drug on hand limited the doses utilized for
each study. Therefore, chow containing 0.05% of each compound
was administered to the young rats in the 7 week diabetes study (ca.
80 mg/kg/day dose from feeding studies) while chow containing
0.025% were administered to the much larger rats in the 26 week
irradiation study (ca. 20 g/kg/day dose from feeding studies).
Since the pharmacokinetics of the compounds have not been
determined, rats orally received compounds mixed in chow rather
than receiving a fixed dose by gavage daily to reduce the potential
effects of systemic half-life differences. Rats typically eat when
active (awake). Therefore, the effects of a potential short half life
on biological activity would be more evident in rats receiving a
single bolus of 80 mg/kg/day drug than those receiving low doses
of drug adding up to 80 mg/kg/day. While clearly additional
studies are required to define the pharmacokinetics and specific
efficacy of these compounds, the present study presents a proof of
concept that multi-functional antioxidants show promise in
significantly delaying ROS generated components of cataract
development.
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